Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

72 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Behavioral versus pharmacological treatments of obsessive compulsive disorder: a meta-analysis.
Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ, Henk HJ. Kobak KA, et al. Psychopharmacology (Berl). 1998 Apr;136(3):205-16. doi: 10.1007/s002130050558. Psychopharmacology (Berl). 1998. PMID: 9566805
St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind study.
Kobak KA, Taylor LV, Bystritsky A, Kohlenberg CJ, Greist JH, Tucker P, Warner G, Futterer R, Vapnik T. Kobak KA, et al. Int Clin Psychopharmacol. 2005 Nov;20(6):299-304. doi: 10.1097/00004850-200511000-00003. Int Clin Psychopharmacol. 2005. PMID: 16192837 Clinical Trial.
A new approach to rater training and certification in a multicenter clinical trial.
Kobak KA, Lipsitz JD, Williams JB, Engelhardt N, Bellew KM. Kobak KA, et al. J Clin Psychopharmacol. 2005 Oct;25(5):407-12. doi: 10.1097/01.jcp.0000177666.35016.a0. J Clin Psychopharmacol. 2005. PMID: 16160614
Antidepressant medication management and Health Plan Employer Data Information Set (HEDIS) criteria: reasons for nonadherence.
Kobak KA, Taylor Lv, Katzelnick DJ, Olson N, Clagnaz P, Henk HJ. Kobak KA, et al. J Clin Psychiatry. 2002 Aug;63(8):727-32. doi: 10.4088/jcp.v63n0811. J Clin Psychiatry. 2002. PMID: 12197454
Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control.
Greist JH, Marks IM, Baer L, Kobak KA, Wenzel KW, Hirsch MJ, Mantle JM, Clary CM. Greist JH, et al. Among authors: kobak ka. J Clin Psychiatry. 2002 Feb;63(2):138-45. doi: 10.4088/jcp.v63n0209. J Clin Psychiatry. 2002. PMID: 11874215 Clinical Trial.
Fluoxetine in social phobia: a double-blind, placebo-controlled pilot study.
Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ. Kobak KA, et al. J Clin Psychopharmacol. 2002 Jun;22(3):257-62. doi: 10.1097/00004714-200206000-00005. J Clin Psychopharmacol. 2002. PMID: 12006895 Clinical Trial.
Comparison of Site-Based Versus Central Ratings in a Study of Generalized Anxiety Disorder.
Williams JB, Kobak KA, Giller E, Reasner DS, Curry L, Detke MJ. Williams JB, et al. Among authors: kobak ka. J Clin Psychopharmacol. 2015 Dec;35(6):654-60. doi: 10.1097/JCP.0000000000000422. J Clin Psychopharmacol. 2015. PMID: 26488677 Clinical Trial.
St. John's wort in generalized anxiety disorder: three more case reports.
Kobak KA, Taylor Lv, Futterer R, Warner G. Kobak KA, et al. J Clin Psychopharmacol. 2003 Oct;23(5):531-2. doi: 10.1097/01.jcp.0000088921.02635.13. J Clin Psychopharmacol. 2003. PMID: 14520138 No abstract available.
St. John's wort versus placebo in social phobia: results from a placebo-controlled pilot study.
Kobak KA, Taylor LV, Warner G, Futterer R. Kobak KA, et al. J Clin Psychopharmacol. 2005 Feb;25(1):51-8. doi: 10.1097/01.jcp.0000150227.61501.00. J Clin Psychopharmacol. 2005. PMID: 15643100 Clinical Trial.
Site versus centralized raters in a clinical depression trial: impact on patient selection and placebo response.
Kobak KA, Leuchter A, DeBrota D, Engelhardt N, Williams JB, Cook IA, Leon AC, Alpert J. Kobak KA, et al. J Clin Psychopharmacol. 2010 Apr;30(2):193-7. doi: 10.1097/JCP.0b013e3181d20912. J Clin Psychopharmacol. 2010. PMID: 20520295 Clinical Trial.
72 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page